Contact details:
Francesco.rainone@srft.nhs.uk
Qualifications:
MB ChB: University of Vita-Salute San Raffaele Milan, Italy, 2007
CCT (Renal med): University of Vita-Salute San Raffaele Milan, Italy 2013
Present appointments:
- Consultant Renal Physician, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust: April 2014 – present
- Honorary Lecturer in Cardiovascular Sciences, School of Medical Sciences, University of Manchester: January 2019 – present
- Divisional Mortality Lead (Tertiary Medicine): January 2017 – present
- Patient Safety Committee Member (UKKA): June 2019 – present
Previous appointments:
- Locum Consultant Renal Physician, Ospedale San Raffaele, Milan (Italy): 01/04/2013 – 31/07/2014)
- Locum Consultant Renal Physician, Ospedale Civile, Sondrio (Italy): 01/08/2013 – 09/03/2014
- Locum Consultant Renal Physician, Salford Royal NHS Foundation Trust: 04/04/2014 – 09/08/2015
Research interests/expertise:
- Dysproteinaemic renal diseases
- Monoclonal gammopathy of renal significance (MGRS)
- Glomerulonephritis
Current research grants:
- PROTECT-V Trial, Principal Investigator, Cambridge University Hospitals NHS Foundation Trust, (August 2021 – ongoing)
Publications (last 5 years):
2023
McDonnell T, Storrar J, Chinnadurai R, Heal C, Chrysochou C, Ritchie J, Rainone F, Poulikakos D, Kalra P, Sinha S, The epidemiology of primary FSGS including cluster analysis over a 20-year period. BMC Nephrol. 2023 Dec 10;24(1):365.
2022
Storrar J, Gill-Taylor T, Chinnadurai R, Chrysochou C, Poulikakos D, Rainone F, Ritchie J, Lamerton E, Kalra PA, Sinha S. A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades. PLoS One 2022 Oct 13;17(10):e0276053.
2020
Lodge MDS, Abeygunaratne T, Alderson H, Ali I, Brown N, Chrysochou C, Donne R, Erekosima I, Evans P, Flanagan E, Gray S, Green D, Hegarty J, Hyde A, Kalra PA, Lamerton E, Lewis D, Middleton R, New D, Nipah R, O’Donoghue D, O’Riordan E, Poulikakos D, Rainone F, Raman M, Ritchie J, Sinha S, Wood G, Tollitt J. Safely reducing haemodialysis frequency during the COVID-19 pandemic. BMC Nephrol. 2020 Dec 7;21(1):532.